As an investor these projects can be soul destroying when no one wants to supply funding. The numbers and productivity outlook have always looked good.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025